| Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) (NCT07260162) | Institut Cancerologie de l'Ouest | 2027-01-01 |
| Stereotactic Radiotherapy for SPinal Metastases With Limited Extent of Epidural Disease (NCT07656883) | Institut Cancerologie de l'Ouest | 2026-10-01 |
| Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) (NCT07007325) | Institut Cancerologie de l'Ouest | 2026-09-30 |
| Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA) (NCT07575750) | Institut Cancerologie de l'Ouest | 2026-09-01 |
| HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) (NCT06978296) | Institut Cancerologie de l'Ouest | 2026-06-01 |
| Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer (NCT07468838) | Institut Cancerologie de l'Ouest | 2026-05-01 |
| Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease (NCT07601152) | Institut Cancerologie de l'Ouest | 2026-05-01 |
| Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b (NCT06967987) | Institut Cancerologie de l'Ouest | 2026-01-01 |
| Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients (NCT06962163) | Institut Cancerologie de l'Ouest | 2025-12-05 |
| Reproductive Health in Breast Cancer Survivor (NCT06756802) | Institut Cancerologie de l'Ouest | 2025-12-01 |
| Impact of the MRI Restraint System on the Quality of the Synthetic Scan for Intracranial Radiotherapy Treatment (NCT06994702) | Institut Cancerologie de l'Ouest | 2025-05-19 |
| To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer (NCT06800989) | Institut Cancerologie de l'Ouest | 2025-05-15 |
| Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases (NCT06471465) | Institut Cancerologie de l'Ouest | 2025-04-29 |
| Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02) (NCT06681038) | Institut Cancerologie de l'Ouest | 2025-02-01 |
| Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children (NCT06314633) | Institut Cancerologie de l'Ouest | 2024-01-29 |
| Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients (NCT05981326) | Institut Cancerologie de l'Ouest | 2023-10-31 |
| Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy (NCT05840562) | Institut Cancerologie de l'Ouest | 2023-10-20 |
| Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer (NCT05856656) | Institut Cancerologie de l'Ouest | 2023-10-10 |
| Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (NCT06051214) | Institut Cancerologie de l'Ouest | 2023-09-12 |
| Rurality Adapted Physical Activity Sport Health (NCT05981170) | Institut Cancerologie de l'Ouest | 2023-09-01 |
| Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy (NCT04644913) | Institut Cancerologie de l'Ouest | 2022-11-18 |
| Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy (NCT05189366) | Institut Cancerologie de l'Ouest | 2022-10-17 |
| Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique (NCT05527769) | Institut Cancerologie de l'Ouest | 2022-09-07 |
| Surgery and Virtual Reality: Interest of Virtual Reality in Oncology for Procedures Under Local Anesthesia in the Operating Room (NCT05287854) | Institut Cancerologie de l'Ouest | 2022-06-16 |
| Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy (NCT05100355) | Institut Cancerologie de l'Ouest | 2022-03-09 |
| Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures (NCT05343975) | Institut Cancerologie de l'Ouest | 2022-03-02 |
| Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life (NCT05316389) | Institut Cancerologie de l'Ouest | 2022-02-21 |
| Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (NCT04667403) | Institut Cancerologie de l'Ouest | 2022-02-07 |
| Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy (NCT05111197) | Institut Cancerologie de l'Ouest | 2022-01-12 |
| Electrotherapy in the Management of Myofascial Syndrome (NCT04936451) | Institut Cancerologie de l'Ouest | 2022-01-05 |
| Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC (NCT04897763) | Institut Cancerologie de l'Ouest | 2021-12-15 |
| Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases (NCT04890028) | Institut Cancerologie de l'Ouest | 2021-12-03 |
| Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy (NCT04899492) | Institut Cancerologie de l'Ouest | 2021-09-29 |
| Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer (NCT04758780) | Institut Cancerologie de l'Ouest | 2021-09-21 |
| Time to Surgery and Survival Outcomes for Patients With Resected Colorectal Carcinoma: Multicenter Study (BIG RENAPE) (NCT04916054) | Institut Cancerologie de l'Ouest | 2021-06-04 |
| Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy (NCT04327583) | Institut Cancerologie de l'Ouest | 2021-04-07 |
| Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ (NCT04666961) | Institut Cancerologie de l'Ouest | 2021-02-03 |
| Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin (NCT04536805) | Institut Cancerologie de l'Ouest | 2020-11-17 |
| Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA) (NCT04675814) | Institut Cancerologie de l'Ouest | 2020-09-14 |
| Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer (NCT04323722) | Institut Cancerologie de l'Ouest | 2020-09-08 |
| Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors (NCT04704804) | Institut Cancerologie de l'Ouest | 2020-07-24 |
| OP2C : Prialt® Observatory in Clinical Practice (NCT04321408) | Institut Cancerologie de l'Ouest | 2020-07-10 |
| Place of Intrathecal Analgesia to Improve the Quality of Life of Painful Cancer Patients (NCT04388449) | Institut Cancerologie de l'Ouest | 2020-02-20 |
| Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec) (NCT04343820) | Institut Cancerologie de l'Ouest | 2019-12-24 |
| Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology (NCT03948724) | Institut Cancerologie de l'Ouest | 2019-12-11 |
| Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives (NCT04226222) | Institut Cancerologie de l'Ouest | 2019-11-05 |
| Satisfaction and QUality of Life After Breast REconstruction (NCT04329819) | Institut Cancerologie de l'Ouest | 2019-09-03 |
| 64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum) (NCT03951337) | Institut Cancerologie de l'Ouest | 2019-04-26 |
| Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers (NCT03961737) | Institut Cancerologie de l'Ouest | 2019-04-02 |
| Intravenous Chemotherapy and Plant-based Dietary Supplements (NCT03959618) | Institut Cancerologie de l'Ouest | 2019-04-02 |
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) (NCT03795207) | Institut Cancerologie de l'Ouest | 2019-03-21 |
| Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery (NCT03794388) | Institut Cancerologie de l'Ouest | 2019-03-19 |
| Cancer Related Cognitive Impairment (NCT03949322) | Institut Cancerologie de l'Ouest | 2019-02-28 |
| Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma (NCT03630913) | Institut Cancerologie de l'Ouest | 2019-01-08 |
| Clinico-biological Data Collection Study of Metastatic Breast Cancer (NCT03958136) | Institut Cancerologie de l'Ouest | 2018-12-24 |
| Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients (NCT03630666) | Institut Cancerologie de l'Ouest | 2018-12-04 |
| Prophylactic Noninvasive Ventilation in vs Postoperative Standard Care in High Risk Patients According to ARISCAT Score (NCT03629431) | Institut Cancerologie de l'Ouest | 2017-11-03 |